We are live on ! Find out more
CIP

Convergence Investment Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
-4.2%
1 Year Est. Return
+87.75%
3 Year Est. Return
+284.26%
5 Year Est. Return
+379.02%
10 Year Est. Return
+1,390.46%
AUM
$153M
AUM Growth
-$12.1M
Cap. Flow
-$1.82M
Cap. Flow %
-1.19%
Top 10 Hldgs %
21.35%
Holding
258
New
56
Increased
66
Reduced
77
Closed
59

Top Buys

Rank Stock Value
1
LAZ icon
Lazard
LAZ
+$1.25M
2
GILD icon
Gilead Sciences
GILD
+$1.17M
3
EIX icon
Edison International
EIX
+$1.14M
4
AMGN icon
Amgen
AMGN
+$1.12M
5
CSCO icon
Cisco
CSCO
+$963K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.41M
2
HPQ icon
HP
HPQ
+$1.91M
3
MPC icon
Marathon Petroleum
MPC
+$1.47M
4
DUK icon
Duke Energy
DUK
+$1.36M
5
JEF icon
Jefferies Financial Group
JEF
+$1.12M

Sector Composition

Rank Sector Weight
1 Technology 19.11%
2 Healthcare 16.75%
3 Financials 16.1%
4 Consumer Discretionary 8.77%
5 Communication Services 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALSN icon
201
Allison Transmission
ALSN
$9.82B
– –
-4,205
Closed -$162K
AMD icon
202
Advanced Micro Devices
AMD
$789B
– –
-2,725
Closed -$208K
AMKR icon
203
Amkor Technology
AMKR
$13.7B
– –
-19,856
Closed -$337K
ATKR icon
204
Atkore
ATKR
$3.16B
– –
-1,548
Closed -$128K
AVT icon
205
Avnet
AVT
$7.92B
– –
-8,393
Closed -$360K
AVTR icon
206
Avantor
AVTR
$9.19B
– –
-10,365
Closed -$322K
BANR icon
207
Banner Corp
BANR
$2.4B
– –
-2,857
Closed -$161K
BG icon
208
Bunge Global
BG
$20.8B
– –
-2,995
Closed -$272K
BOX icon
209
Box
BOX
$4.6B
– –
-11,905
Closed -$299K
CWK icon
210
Cushman & Wakefield Ltd
CWK
$3.25B
– –
-7,200
Closed -$110K
DBX icon
211
Dropbox
DBX
$8.12B
– –
-15,313
Closed -$321K
DELL icon
212
Dell
DELL
$293B
– –
-8,430
Closed -$390K
DFS
213
DELISTED
Discover Financial Services
DFS
– –
-2,163
Closed -$205K
DK icon
214
Delek US
DK
$3.58B
– –
-8,229
Closed -$213K
DTE icon
215
DTE Energy
DTE
$29.1B
– –
-1,404
Closed -$178K
DUK icon
216
Duke Energy
DUK
$97.3B
– –
-12,698
Closed -$1.36M
DXC icon
217
DXC Technology
DXC
$1.73B
– –
-9,789
Closed -$297K
EMR icon
218
Emerson Electric
EMR
$88.3B
– –
-12,585
Closed -$1M
EVR icon
219
Evercore
EVR
$11.8B
– –
-2,474
Closed -$232K
FLR icon
220
Fluor
FLR
$7.96B
– –
-4,712
Closed -$115K
GNW icon
221
Genworth Financial
GNW
$3.71B
– –
-21,417
Closed -$76K
HLI icon
222
Houlihan Lokey
HLI
$9.02B
– –
-2,124
Closed -$168K
HOLX
223
DELISTED
Hologic
HOLX
– –
-3,648
Closed -$253K
HPQ icon
224
HP
HPQ
$27.5B
– –
-58,154
Closed -$1.91M
HTH icon
225
Hilltop Holdings
HTH
$2.24B
– –
-5,045
Closed -$134K
7 8
9
10 11

Similar funds

MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return
SFP
Shepherd Financial Partners Winchester, Massachusetts $1.05B AUM 22.07% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return
HW
HORAN Wealth Cincinnati, Ohio $1.05B AUM 17.67% 1-Year Est. Return
LAM
L2 Asset Management Wayland, Massachusetts $1.05B AUM 29.07% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
CIA
Compass Ion Advisors Conshohocken, Pennsylvania $1.05B AUM 16.28% 1-Year Est. Return

Convergence Investment Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Convergence Investment Partners held 258 positions worth $153M, down 7.3% from $165M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Convergence Investment Partners's Q3 2022 filing shows 56 new, 66 increased, 77 reduced and 59 closed positions. Its largest new stake was Lazard: 34,896 shares worth $1.11M. The largest sale was Pfizer, an estimated $2.41M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Convergence Investment Partners's largest Q3 2022 buy was Lazard: 34,896 shares worth $1.11M.
  • Convergence Investment Partners added most to Gilead Sciences in Q3 2022, an estimated $1.17M increase.
  • Convergence Investment Partners's biggest Q3 2022 reduction was Pfizer, cutting an estimated $2.41M.
  • Convergence Investment Partners fully exited HP in Q3 2022, selling an estimated $1.91M.
  • Convergence Investment Partners's ten largest holdings make up 21% of its $153M portfolio in Q3 2022.
  • Convergence Investment Partners opened 56 new positions and closed 59 in Q3 2022.
  • Convergence Investment Partners's portfolio value fell 7.3% quarter-over-quarter to $153M.

Based on Convergence Investment Partners's 13F filing for Q3 2022, filed 8 Nov 2022.